世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の非経口剤形市場レポート、歴史と予測2018-2029年、メーカー別内訳データ、主要地域別、タイプ別、用途別


Global Parenteral Dosage Form Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

QYResearch社の調査レポート「非経口投与剤形」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の非経口剤形市場は、2023年から2029年の間に年平均成長率%... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年10月23日 US$3,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

QYResearch社の調査レポート「非経口投与剤形」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の非経口剤形市場は、2023年から2029年の間に年平均成長率%で、2022年の100万米ドルから増加し、2029年には100万米ドルに達すると予測されています。病院や診療所からの需要が業界の主要な推進力となっている。

IQVIA Instituteが発表したGlobal Use of Medicines 2023によると、2022年の世界の薬剤費は約1兆4,800億米ドル(COVIDワクチンと治療関連費を除く)であり、今後数年間は3%〜6%の割合で成長すると予測されている。医薬品支出に関しては、中国のこの数字は2022年には約1660億ドルであった。医薬品への支出は今後数年で増加すると予想される。需要の観点からは、人口の高齢化の傾向、住民の富の増加、健康意識の向上が医薬品需要を牽引する。
Global Use of Medicines 2023によると、米国市場は2022年に正味工場出荷ベースで約629億米ドルを医薬品に費やした。インフレ削減法(IRA)が処方薬価格を引き下げるために640億米ドルを支出し、新しい治療法の採用が今後数年間で増加すると予想されるため、全体的な成長は鈍化する。そのほか、医薬品流通における工場出荷時割引やリベート、特許失効の影響、ジェネリック医薬品やバイオシミラー医薬品の競争も米国医薬品市場に影響を与えるだろう。

レポートの範囲
本レポートは、過去の分析(2018-2022年)と予測計算(2023-2029年)に基づき、読者が世界の非経口剤形市場を多角的に包括的に理解することを目的とし、読者の戦略と意思決定に十分なサポートを提供します。
レポートに掲載されているメーカー、タイプ、用途、地域
企業別
アシュランド
テプネル・ファーマ・サービス
アセンジア・ファーマシューティカルズ
サーモフィッシャーサイエンティフィック
プロジェクト・ファーマスーティックス
ロンザ
BOCサイエンシズ
タイプ別セグメント
注射用エマルジョン
注射用粉末
注射用ゲル
用途別セグメント
病院
クリニック
その他
地域別セグメント
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
本レポートの各章は、読者が非経口剤形市場をさらに理解するための詳細な情報を提供します:
第1章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品定義、製品タイプ、各タイプの数量および収益分析。
第2章:売上高と収益の比較を含むメーカーの競争状況、非経口投与フォームのメーカーの商業日、各メーカーが提供する製品タイプ、M&A活動、非経口投与フォーム業界で発生した拡張活動。
第3章:北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける非経口投与剤形の過去(2018-2022年)および予測(2023-2029年)の数量および収益分析。
第4章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途、各用途の数量および収益分析。
第5章から第9章:北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカの国別レベル分析、数量および収益分析を含む。
第10章:メーカー概要:本社、連絡先、主要事業、非経口投与剤形紹介などの企業の基本情報をカバー。また、各企業の売上高、収益、価格、グロスマージン、最近の動向もこのパートに含まれています。
第11章:原材料、製造コストのような産業チェーンがカバーされています。加えて、市場機会と課題もこの章で強調されている。
第12章:市場チャネル、流通業者と顧客がリストアップされています。
第13章包括的調査に基づくQYResearchの非経口剤形市場の結論。
第14章:QYResearchが採用した方法論とデータソース。


ページTOPに戻る


目次

1 Parenteral Dosage Form Market Overview
1.1 Parenteral Dosage Form Product Overview
1.2 Parenteral Dosage Form Market Segment by Type
1.2.1 Emulsions for Injection
1.2.2 Powders for Injection
1.2.3 Gels for Injection
1.3 Global Parenteral Dosage Form Market Size by Type
1.3.1 Global Parenteral Dosage Form Market Size Overview by Type (2018-2029)
1.3.2 Global Parenteral Dosage Form Historic Market Size Review by Type (2018-2023)
1.3.3 Global Parenteral Dosage Form Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.2 Europe Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
2 Global Parenteral Dosage Form Market Competition by Company
2.1 Global Top Players by Parenteral Dosage Form Sales (2018-2023)
2.2 Global Top Players by Parenteral Dosage Form Revenue (2018-2023)
2.3 Global Top Players by Parenteral Dosage Form Price (2018-2023)
2.4 Global Top Manufacturers Parenteral Dosage Form Manufacturing Base Distribution, Sales Area, Product Type
2.5 Parenteral Dosage Form Market Competitive Situation and Trends
2.5.1 Parenteral Dosage Form Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Parenteral Dosage Form Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2022)
2.7 Date of Key Manufacturers Enter into Parenteral Dosage Form Market
2.8 Key Manufacturers Parenteral Dosage Form Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Parenteral Dosage Form Status and Outlook by Region
3.1 Global Parenteral Dosage Form Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Parenteral Dosage Form Historic Market Size by Region
3.2.1 Global Parenteral Dosage Form Sales in Volume by Region (2018-2023)
3.2.2 Global Parenteral Dosage Form Sales in Value by Region (2018-2023)
3.2.3 Global Parenteral Dosage Form Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Parenteral Dosage Form Forecasted Market Size by Region
3.3.1 Global Parenteral Dosage Form Sales in Volume by Region (2024-2029)
3.3.2 Global Parenteral Dosage Form Sales in Value by Region (2024-2029)
3.3.3 Global Parenteral Dosage Form Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Parenteral Dosage Form by Application
4.1 Parenteral Dosage Form Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Parenteral Dosage Form Market Size by Application
4.2.1 Global Parenteral Dosage Form Market Size Overview by Application (2018-2029)
4.2.2 Global Parenteral Dosage Form Historic Market Size Review by Application (2018-2023)
4.2.3 Global Parenteral Dosage Form Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.2 Europe Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
5 North America Parenteral Dosage Form by Country
5.1 North America Parenteral Dosage Form Historic Market Size by Country
5.1.1 North America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Parenteral Dosage Form Sales in Volume by Country (2018-2023)
5.1.3 North America Parenteral Dosage Form Sales in Value by Country (2018-2023)
5.2 North America Parenteral Dosage Form Forecasted Market Size by Country
5.2.1 North America Parenteral Dosage Form Sales in Volume by Country (2024-2029)
5.2.2 North America Parenteral Dosage Form Sales in Value by Country (2024-2029)
6 Europe Parenteral Dosage Form by Country
6.1 Europe Parenteral Dosage Form Historic Market Size by Country
6.1.1 Europe Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Parenteral Dosage Form Sales in Volume by Country (2018-2023)
6.1.3 Europe Parenteral Dosage Form Sales in Value by Country (2018-2023)
6.2 Europe Parenteral Dosage Form Forecasted Market Size by Country
6.2.1 Europe Parenteral Dosage Form Sales in Volume by Country (2024-2029)
6.2.2 Europe Parenteral Dosage Form Sales in Value by Country (2024-2029)
7 Asia-Pacific Parenteral Dosage Form by Region
7.1 Asia-Pacific Parenteral Dosage Form Historic Market Size by Region
7.1.1 Asia-Pacific Parenteral Dosage Form Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Parenteral Dosage Form Forecasted Market Size by Region
7.2.1 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2024-2029)
8 Latin America Parenteral Dosage Form by Country
8.1 Latin America Parenteral Dosage Form Historic Market Size by Country
8.1.1 Latin America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Parenteral Dosage Form Sales in Volume by Country (2018-2023)
8.1.3 Latin America Parenteral Dosage Form Sales in Value by Country (2018-2023)
8.2 Latin America Parenteral Dosage Form Forecasted Market Size by Country
8.2.1 Latin America Parenteral Dosage Form Sales in Volume by Country (2024-2029)
8.2.2 Latin America Parenteral Dosage Form Sales in Value by Country (2024-2029)
9 Middle East and Africa Parenteral Dosage Form by Country
9.1 Middle East and Africa Parenteral Dosage Form Historic Market Size by Country
9.1.1 Middle East and Africa Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Parenteral Dosage Form Forecasted Market Size by Country
9.2.1 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Ashland
10.1.1 Ashland Company Information
10.1.2 Ashland Introduction and Business Overview
10.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Ashland Parenteral Dosage Form Products Offered
10.1.5 Ashland Recent Development
10.2 Tepnel Pharma Services
10.2.1 Tepnel Pharma Services Company Information
10.2.2 Tepnel Pharma Services Introduction and Business Overview
10.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Tepnel Pharma Services Parenteral Dosage Form Products Offered
10.2.5 Tepnel Pharma Services Recent Development
10.3 Ascendia Pharmaceuticals
10.3.1 Ascendia Pharmaceuticals Company Information
10.3.2 Ascendia Pharmaceuticals Introduction and Business Overview
10.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Products Offered
10.3.5 Ascendia Pharmaceuticals Recent Development
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Information
10.4.2 Thermo Fisher Scientific Introduction and Business Overview
10.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Thermo Fisher Scientific Parenteral Dosage Form Products Offered
10.4.5 Thermo Fisher Scientific Recent Development
10.5 ProJect Pharmaceutics
10.5.1 ProJect Pharmaceutics Company Information
10.5.2 ProJect Pharmaceutics Introduction and Business Overview
10.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ProJect Pharmaceutics Parenteral Dosage Form Products Offered
10.5.5 ProJect Pharmaceutics Recent Development
10.6 Lonza
10.6.1 Lonza Company Information
10.6.2 Lonza Introduction and Business Overview
10.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Lonza Parenteral Dosage Form Products Offered
10.6.5 Lonza Recent Development
10.7 BOC Sciences
10.7.1 BOC Sciences Company Information
10.7.2 BOC Sciences Introduction and Business Overview
10.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BOC Sciences Parenteral Dosage Form Products Offered
10.7.5 BOC Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Parenteral Dosage Form Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Parenteral Dosage Form Industrial Chain Analysis
11.4 Parenteral Dosage Form Market Dynamics
11.4.1 Parenteral Dosage Form Industry Trends
11.4.2 Parenteral Dosage Form Market Drivers
11.4.3 Parenteral Dosage Form Market Challenges
11.4.4 Parenteral Dosage Form Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Parenteral Dosage Form Distributors
12.3 Parenteral Dosage Form Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る


 

Summary

Parenteral Dosage Form report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Parenteral Dosage Form market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Parenteral Dosage Form market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
Segment by Type
Emulsions for Injection
Powders for Injection
Gels for Injection
Segment by Application
Hospital
Clinic
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Parenteral Dosage Form market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Parenteral Dosage Form, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Parenteral Dosage Form industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Parenteral Dosage Form in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Parenteral Dosage Form introduction, etc. Parenteral Dosage Form Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Parenteral Dosage Form market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.



ページTOPに戻る


Table of Contents

1 Parenteral Dosage Form Market Overview
1.1 Parenteral Dosage Form Product Overview
1.2 Parenteral Dosage Form Market Segment by Type
1.2.1 Emulsions for Injection
1.2.2 Powders for Injection
1.2.3 Gels for Injection
1.3 Global Parenteral Dosage Form Market Size by Type
1.3.1 Global Parenteral Dosage Form Market Size Overview by Type (2018-2029)
1.3.2 Global Parenteral Dosage Form Historic Market Size Review by Type (2018-2023)
1.3.3 Global Parenteral Dosage Form Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.2 Europe Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Type (2018-2023)
2 Global Parenteral Dosage Form Market Competition by Company
2.1 Global Top Players by Parenteral Dosage Form Sales (2018-2023)
2.2 Global Top Players by Parenteral Dosage Form Revenue (2018-2023)
2.3 Global Top Players by Parenteral Dosage Form Price (2018-2023)
2.4 Global Top Manufacturers Parenteral Dosage Form Manufacturing Base Distribution, Sales Area, Product Type
2.5 Parenteral Dosage Form Market Competitive Situation and Trends
2.5.1 Parenteral Dosage Form Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Parenteral Dosage Form Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parenteral Dosage Form as of 2022)
2.7 Date of Key Manufacturers Enter into Parenteral Dosage Form Market
2.8 Key Manufacturers Parenteral Dosage Form Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Parenteral Dosage Form Status and Outlook by Region
3.1 Global Parenteral Dosage Form Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Parenteral Dosage Form Historic Market Size by Region
3.2.1 Global Parenteral Dosage Form Sales in Volume by Region (2018-2023)
3.2.2 Global Parenteral Dosage Form Sales in Value by Region (2018-2023)
3.2.3 Global Parenteral Dosage Form Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Parenteral Dosage Form Forecasted Market Size by Region
3.3.1 Global Parenteral Dosage Form Sales in Volume by Region (2024-2029)
3.3.2 Global Parenteral Dosage Form Sales in Value by Region (2024-2029)
3.3.3 Global Parenteral Dosage Form Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Parenteral Dosage Form by Application
4.1 Parenteral Dosage Form Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Parenteral Dosage Form Market Size by Application
4.2.1 Global Parenteral Dosage Form Market Size Overview by Application (2018-2029)
4.2.2 Global Parenteral Dosage Form Historic Market Size Review by Application (2018-2023)
4.2.3 Global Parenteral Dosage Form Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.2 Europe Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Parenteral Dosage Form Sales Breakdown by Application (2018-2023)
5 North America Parenteral Dosage Form by Country
5.1 North America Parenteral Dosage Form Historic Market Size by Country
5.1.1 North America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Parenteral Dosage Form Sales in Volume by Country (2018-2023)
5.1.3 North America Parenteral Dosage Form Sales in Value by Country (2018-2023)
5.2 North America Parenteral Dosage Form Forecasted Market Size by Country
5.2.1 North America Parenteral Dosage Form Sales in Volume by Country (2024-2029)
5.2.2 North America Parenteral Dosage Form Sales in Value by Country (2024-2029)
6 Europe Parenteral Dosage Form by Country
6.1 Europe Parenteral Dosage Form Historic Market Size by Country
6.1.1 Europe Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Parenteral Dosage Form Sales in Volume by Country (2018-2023)
6.1.3 Europe Parenteral Dosage Form Sales in Value by Country (2018-2023)
6.2 Europe Parenteral Dosage Form Forecasted Market Size by Country
6.2.1 Europe Parenteral Dosage Form Sales in Volume by Country (2024-2029)
6.2.2 Europe Parenteral Dosage Form Sales in Value by Country (2024-2029)
7 Asia-Pacific Parenteral Dosage Form by Region
7.1 Asia-Pacific Parenteral Dosage Form Historic Market Size by Region
7.1.1 Asia-Pacific Parenteral Dosage Form Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Parenteral Dosage Form Forecasted Market Size by Region
7.2.1 Asia-Pacific Parenteral Dosage Form Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Parenteral Dosage Form Sales in Value by Region (2024-2029)
8 Latin America Parenteral Dosage Form by Country
8.1 Latin America Parenteral Dosage Form Historic Market Size by Country
8.1.1 Latin America Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Parenteral Dosage Form Sales in Volume by Country (2018-2023)
8.1.3 Latin America Parenteral Dosage Form Sales in Value by Country (2018-2023)
8.2 Latin America Parenteral Dosage Form Forecasted Market Size by Country
8.2.1 Latin America Parenteral Dosage Form Sales in Volume by Country (2024-2029)
8.2.2 Latin America Parenteral Dosage Form Sales in Value by Country (2024-2029)
9 Middle East and Africa Parenteral Dosage Form by Country
9.1 Middle East and Africa Parenteral Dosage Form Historic Market Size by Country
9.1.1 Middle East and Africa Parenteral Dosage Form Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Parenteral Dosage Form Forecasted Market Size by Country
9.2.1 Middle East and Africa Parenteral Dosage Form Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Parenteral Dosage Form Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Ashland
10.1.1 Ashland Company Information
10.1.2 Ashland Introduction and Business Overview
10.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Ashland Parenteral Dosage Form Products Offered
10.1.5 Ashland Recent Development
10.2 Tepnel Pharma Services
10.2.1 Tepnel Pharma Services Company Information
10.2.2 Tepnel Pharma Services Introduction and Business Overview
10.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Tepnel Pharma Services Parenteral Dosage Form Products Offered
10.2.5 Tepnel Pharma Services Recent Development
10.3 Ascendia Pharmaceuticals
10.3.1 Ascendia Pharmaceuticals Company Information
10.3.2 Ascendia Pharmaceuticals Introduction and Business Overview
10.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Products Offered
10.3.5 Ascendia Pharmaceuticals Recent Development
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Information
10.4.2 Thermo Fisher Scientific Introduction and Business Overview
10.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Thermo Fisher Scientific Parenteral Dosage Form Products Offered
10.4.5 Thermo Fisher Scientific Recent Development
10.5 ProJect Pharmaceutics
10.5.1 ProJect Pharmaceutics Company Information
10.5.2 ProJect Pharmaceutics Introduction and Business Overview
10.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ProJect Pharmaceutics Parenteral Dosage Form Products Offered
10.5.5 ProJect Pharmaceutics Recent Development
10.6 Lonza
10.6.1 Lonza Company Information
10.6.2 Lonza Introduction and Business Overview
10.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Lonza Parenteral Dosage Form Products Offered
10.6.5 Lonza Recent Development
10.7 BOC Sciences
10.7.1 BOC Sciences Company Information
10.7.2 BOC Sciences Introduction and Business Overview
10.7.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BOC Sciences Parenteral Dosage Form Products Offered
10.7.5 BOC Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Parenteral Dosage Form Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Parenteral Dosage Form Industrial Chain Analysis
11.4 Parenteral Dosage Form Market Dynamics
11.4.1 Parenteral Dosage Form Industry Trends
11.4.2 Parenteral Dosage Form Market Drivers
11.4.3 Parenteral Dosage Form Market Challenges
11.4.4 Parenteral Dosage Form Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Parenteral Dosage Form Distributors
12.3 Parenteral Dosage Form Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る